ATC Group: R03AC02 Salbutamol

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R03AC02 in the ATC hierarchy

Level Code Title
1 R Respiratory system
2 R03 Drugs for obstructive airway diseases
3 R03A Adrenergics, inhalants
4 R03AC Selective beta-2-adrenoreceptor agonists
5 R03AC02 Salbutamol

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
RESPIR - Respiratory (Inhalation) (aerosol) 0.8 mg
RESPIR - Respiratory (Inhalation) (powder) 0.8 mg
RESPIR - Respiratory (Inhalation) (solution) 10 mg

Active ingredients in R03AC02

Active Ingredient Description
Salbutamol

Salbutamol is a selective β2-agonist providing short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. At therapeutic doses it acts on the β2-adrenoceptors of bronchial muscle. Salbutamol is administered for the symptomatic relief of bronchospasm associated with chronic or acute asthma, bronchitis or other obstructive pulmonary diseases.

Related product monographs

Title Information Source Document Type  
ASTHALIN Respiratory solution Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC
PROVENTIL HFA Inhalation aerosol FDA, National Drug Code (US) MPI, US: SPL/Old
SALAMOL Pressurised inhalation, suspension Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SALBULIN Inhalation powder Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SALBUTAMOL Nebuliser solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SALBUTAMOL Tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
VENTOLIN Solution for inhalation via a nebuliser Υπουργείο Υγείας (CY) MPI, EU: SmPC
VENTOLIN Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
VENTOLIN Syrup Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Albania (AL)

Australia (AU)

Canada (CA)

Croatia (HR)

Cyprus (CY)

France (FR)

Ireland (IE)

Italy (IT)

Lithuania (LT)

Mexico (MX)

Netherlands (NL)

Nigeria (NG)

Romania (RO)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.